In Pharma, launches KPIs often look great… until it’s too late. In this webinar, panelists from Takeda, Chiesi, and Johnson & Johnson discussed why traditional reporting misses early warning signs—and how top teams are spotting hidden risks, acting faster, and building an intelligence layer that goes beyond the dashboard.
Key takeaways:
- Why most pharma KPIs are lagging indicators, and what to watch for instead
- How real-time signals (from DOLs, sentiment, stakeholder actions) expose unseen risks
- Where medical and commercial teams can collaborate around early warnings and unseen opportunities
- How to make ‘insight latency’ a thing of the past
